Ovarian Cancer Research Alliance hosted a free online seminar on April 9th titled “Endometrial Cancer: Understanding Biomarker Testing & Its Value in the Changing Treatment Landscape.”
Dr. Ramez Eskander of UC San Diego Moores NCI-Designated Comprehensive Cancer Center and Dr. Ann Klopp of The University of Texas MD Anderson Cancer Center answered questions live, discussing emerging therapies and sharing other expert insights.
Topics covered included an overview of endometrial and uterine cancer, how to differentiate between genetics and biomarkers, most effective tests in understanding treatment options, what’s new in the treatment landscape for endometrial cancer, targeted therapies currently available for endometrial cancer, and clinical trials currently recruiting for endometrial cancer.
This event was made possible with support from AstraZeneca and Merck.
